We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Drugs for treating disorders.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Drugs for treating disorders - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Drugs for treating disorders Product List

1～15 item / All 15 items

Displayed results
[Research Material] Global Market for Peripheral Neuropathy Treatment

[Research Material] Global Market for Peripheral Neuropathy Treatment

Global Market for Peripheral Neuropathy Treatment: Calcium Channel α2-Delta Ligands, Antidepressants, Opioids, Others, Platinum Agents, Taxanes, ...

This research report (Global Peripheral Neuropathy Treatment Market) investigates and analyzes the current state and outlook for the global market for peripheral neuropathy treatment over the next five years. It includes information on the overview of the global peripheral neuropathy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the peripheral neuropathy treatment market include calcium channel α2-delta ligands, antidepressants, opioids, and others, while the segments by application include platinum agents, taxanes, vinca alkaloids, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for peripheral neuropathy treatment. The report also includes the market share of major companies in peripheral neuropathy treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Skin Radiation Injury Treatment

[Research Material] Global Market for Skin Radiation Injury Treatment

World Market for Skin Radiation Injury Treatment: Non-Steroidal Anti-Inflammatory Drugs, Antihistamines, Antibiotics, Corticosteroids, Others, Hospitals, Clinics ...

This research report (Global Cutaneous Radiation Injury Treatment Market) investigates and analyzes the current state and future outlook of the global market for cutaneous radiation injury treatment over the next five years. It includes information on the overview of the global cutaneous radiation injury treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include non-steroidal anti-inflammatory drugs, antihistamines, antibiotics, corticosteroids, and others, while the segments by application focus on hospitals, clinics, outpatient surgical centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for cutaneous radiation injury treatment. It also includes the market share of major companies in the cutaneous radiation injury treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for the Treatment of Diabetic Peripheral Neuropathy

[Research Material] Global Market for the Treatment of Diabetic Peripheral Neuropathy

Global Market for Treatment of Diabetic Peripheral Neuropathy: Antimunocell, ASP-8477, BNV-222, Capsaicin, CBX-129801 ...

This research report (Global Diabetic Peripheral Neuropathy Treatment Market) investigates and analyzes the current status and outlook for the global market for diabetic peripheral neuropathy treatment over the next five years. It includes information on the overview of the global diabetic peripheral neuropathy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the diabetic peripheral neuropathy treatment market include Antimunocell, ASP-8477, BNV-222, Capsaicin, CBX-129801, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for diabetic peripheral neuropathy treatment. It also includes the market share of major companies in diabetic peripheral neuropathy treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Urea Cycle Disorder (UCD) Treatment

[Research Material] Global Market for Urea Cycle Disorder (UCD) Treatment

Global Market for Urea Cycle Disorder (UCD) Treatment: Amino Acid Formulas, Phenylbutyrate, Sodium Benzoate, Others, Hospital Pharmacies, Retail...

This research report (Global Urea Cycle Disorders (UCD) Treatment Market) investigates and analyzes the current status and outlook for the global market for urea cycle disorder (UCD) treatment over the next five years. It includes information on the overview of the global urea cycle disorder (UCD) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the urea cycle disorder (UCD) treatment market by type include amino acid formulas, phenylbutyrate, sodium benzoate, and others, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for urea cycle disorder (UCD) treatment. It also includes the market share of major companies in the urea cycle disorder (UCD) treatment market, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Diabetic Neuropathy Treatment

[Research Material] The Global Market for Diabetic Neuropathy Treatment

Global Market for Diabetes-Related Neuropathy Treatment: Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy, Hospitals, Clinics, Pharmacies

This research report (Global Diabetic Neuropathy Treatment Market) investigates and analyzes the current state and outlook for the global market for diabetic neuropathy treatment over the next five years. It includes information on the overview of the global diabetic neuropathy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the diabetic neuropathy treatment market focus on peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy, while the segments by application target hospitals, clinics, and pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for diabetic neuropathy treatment. It also includes the market share of major companies in diabetic neuropathy treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Peptide Metabolism Disorder Therapeutics

[Research Material] Global Market for Peptide Metabolism Disorder Therapeutics

Global Market for Peptide Metabolism Disorder Treatments: Exenatide, Liraglutide, Others, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Peptide Based Metabolic Disorders Therapeutics) investigates and analyzes the current status and outlook for the global market of peptide metabolic disorder therapeutics over the next five years. It includes information on the global overview of the peptide metabolic disorder therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Exenatide, Liraglutide, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for peptide metabolic disorder therapeutics. The report also includes the market share of major companies in peptide metabolic disorder therapeutics, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Radiation Injury Treatment Drugs

[Research Material] Global Market for Radiation Injury Treatment Drugs

World Market for Radiation Injury Treatment Drugs: Aerosurf, BMX-001, C-2E2, C-2E5, Des-Asp Angiotensin 1, ...

This research report (Global Radiation Injury Drugs Market) investigates and analyzes the current status and outlook for the global market of radiation injury treatment drugs over the next five years. It includes information on the overview of the global radiation injury treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Aerosurf, BMX-001, C-2E2, C-2E5, Des-Asp Angiotensin 1, DG-3, and others, while the segments by application focus on ASC, hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for radiation injury treatment drugs. The report also includes the market share of major companies in the radiation injury treatment drugs sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Thyroid Disorder Treatment

[Research Material] Global Market for Thyroid Disorder Treatment

Global Market for Thyroid Disorder Treatment: Hyperthyroidism, Hypothyroidism, Others, Male, Female

This research report (Global Thyroid Gland Disorder Treatment Market) investigates and analyzes the current state and outlook for the global market for thyroid disorder treatment over the next five years. It includes information on the overview of the global thyroid disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the thyroid disorder treatment market include hyperthyroidism, hypothyroidism, and others, while the segments by application target males and females. The regional segments calculate the market size for thyroid disorder treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in thyroid disorder treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Diabetes Neuropathy Treatment Drugs

[Research Material] Global Market for Diabetes Neuropathy Treatment Drugs

Global Market for Diabetes Neuropathy Treatment Drugs: Capsules, Pills, Others, Symmetrical Neuropathy, Focal and Multifocal Neuropathy

This research report (Global Diabetic Neurological Disorder Therapeutics) investigates and analyzes the current status and outlook for the global market of diabetic neuropathy therapeutics over the next five years. It includes information on the overview of the global diabetic neuropathy therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include capsules, pills, and others, while the segments by application focus on symmetric neuropathy and focal/multifocal neuropathy. The regional segments calculate the market size for diabetic neuropathy therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in diabetic neuropathy therapeutics, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Metabolic Disorder Therapeutics

[Research Material] Global Market for Metabolic Disorder Therapeutics

Global Market for Metabolic Disorder Treatments: Dysmyelinating Leukoencephalopathy, Globoid Cell Leukodystrophy, Hepatic Encephalopathy, Others, Diabetes, Obesity, Hypercholesterolemia...

This research report (Global Metabolic Disorders Therapeutics Market) investigates and analyzes the current state and outlook for the global market for metabolic disorder therapeutics over the next five years. It includes information on the overview of the global metabolic disorder therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include disorders such as dysmyelinating leukodystrophy, globoid cell leukodystrophy, hepatic encephalopathy, and others, while the segments by application focus on diabetes, obesity, hypercholesterolemia, lysosomal storage disorders, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for metabolic disorder therapeutics. It also includes the market share of major companies in metabolic disorder therapeutics, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Medications for Post-Traumatic Stress Disorder (PTSD)

[Research Material] The Global Market for Medications for Post-Traumatic Stress Disorder (PTSD)

Global Market for Post-Traumatic Stress Disorder (PTSD) Treatment Drugs: Antidepressants, Anxiolytics, Hospitals, Pharmacies, Others

This research report (Global Post-Traumatic Stress Disorder (PTSD) Therapy) investigates and analyzes the current state and outlook for the global market for medications treating post-traumatic stress disorder (PTSD) over the next five years. It includes information on the global PTSD medication market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for PTSD medications by type focus on antidepressants and anxiolytics, while the segments by application target hospitals, pharmacies, and others. The regional segments calculate the market size for PTSD medications by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the PTSD medication sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

[Research Material] Global Market for the Treatment of Chemotherapy-Induced Peripheral Neuropathy

Global Market for Chemotherapy-Induced Peripheral Neuropathy Treatment: Calcium Channel α2-Delta Ligands, Antidepressants, Opioids, Others, White ...

This research report (Global Chemotherapy Induced Peripheral Neuropathy Treatment Market) investigates and analyzes the current status and outlook for the global market for chemotherapy-induced peripheral neuropathy treatment over the next five years. It includes information on the overview of the global chemotherapy-induced peripheral neuropathy treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include calcium channel α2-delta ligands, antidepressants, opioids, and others, while the segments by application focus on platinum agents, taxanes, vinca alkaloids, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for chemotherapy-induced peripheral neuropathy treatment. It also includes the market share of major companies in chemotherapy-induced peripheral neuropathy treatment, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

[Research Material] The Global Market for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Global Market for the Treatment of Hypoactive Sexual Desire Disorder (HSDD): Buspirone, Bupropion, Testosterone, Flibanserin, Bremelanotide, Cognitive Behavioral Therapy...

This research report (Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market) investigates and analyzes the current status and future outlook of the global market for the treatment of hypoactive sexual desire disorder (HSDD) over the next five years. It includes information on the overview of the global HSDD treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include buspirone, bupropion, testosterone, flibanserin, bremelanotide, and cognitive behavioral therapy, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for HSDD treatment. It also includes the market share of major companies in the HSDD treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Materials] Global Market for Musculoskeletal Disorder Treatments

[Research Materials] Global Market for Musculoskeletal Disorder Treatments

Global Market for Musculoskeletal Disorder Treatments: OTC, Prescription Drugs, Hospitals, Retail Pharmacies

This research report (Global Musculoskeletal Disorders Treatment Market) investigates and analyzes the current state and outlook for the global market for musculoskeletal disorder treatments over the next five years. It includes information on the overview of the global musculoskeletal disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the musculoskeletal disorder treatment market focus on OTC and prescription drugs, while the segments by application target hospitals and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for musculoskeletal disorder treatments. It also includes the market share of major companies in the musculoskeletal disorder treatment sector, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Retinal Disorder Treatments

[Research Material] Global Market for Retinal Disorder Treatments

Global Market for Retinal Disorder Treatments: Gels, Capsules & Tablets, Eye Drops, Ointments, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

This research report (Global Retinal Disorder Treatment Market) investigates and analyzes the current state and outlook for the global market for retinal disorder treatments over the next five years. It includes information on the overview of the global retinal disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include gels, capsules & tablets, eye drops, and ointments, while the segments by application focus on hospital pharmacies, online pharmacies, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for retinal disorder treatments. It also includes the market share of major companies in retinal disorder treatments, product and business overviews, and sales performance.

  • Other services
  • Drugs for treating disorders

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Drugs for treating disorders

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.